HomeNXTG • TLV
add
Nextage Therapeutics Ltd
Previous close
ILA 77.90
Year range
ILA 59.20 - ILA 119.00
Market cap
63.15M ILS
P/E ratio
-
Dividend yield
-
Primary exchange
TLV
Market news
Financials
Income Statement
Revenue
Net income
| (ILS) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 52.00K | -85.41% |
Operating expense | 829.50K | -13.14% |
Net income | -2.50M | 18.26% |
Net profit margin | -4.81K | -460.41% |
Earnings per share | — | — |
EBITDA | -807.50K | 5.56% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (ILS) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 253.00K | -47.18% |
Total assets | 353.00K | -67.76% |
Total liabilities | 5.89M | 53.68% |
Total equity | -5.54M | — |
Shares outstanding | 33.70M | — |
Price to book | -4.87 | — |
Return on assets | -576.49% | — |
Return on capital | 38.21% | — |
Cash Flow
Net change in cash
| (ILS) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -2.50M | 18.26% |
Cash from operations | -133.00K | 16.35% |
Cash from investing | -94.00K | -2,188.89% |
Cash from financing | 168.00K | -51.16% |
Net change in cash | -29.50K | -114.71% |
Free cash flow | -491.75K | 26.78% |
About
Founded
1982
Website
Employees
31
